Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_assertion type Assertion NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_head.
- NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_assertion description "[For example, we discovered that estrogen receptor (ER) and histone deacetylase (HDAC), which have recently been identified as two new therapeutic targets of AD, might already have been targeted by the marketed AD drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_provenance.
- NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_assertion evidence source_evidence_literature NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_provenance.
- NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_assertion SIO_000772 20221449 NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_provenance.
- NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_assertion wasDerivedFrom befree-20140225 NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_provenance.
- NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_assertion wasGeneratedBy ECO_0000203 NP651702.RA6ytGL2RchQjv01pGkLPf0TI2FTYtZNWD23C53QmTDbM130_provenance.